Page last updated: 2024-10-24

calmidazolium and Innate Inflammatory Response

calmidazolium has been researched along with Innate Inflammatory Response in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Montezano, AC1
Burger, D1
Paravicini, TM1
Chignalia, AZ1
Yusuf, H1
Almasri, M1
He, Y1
Callera, GE1
He, G1
Krause, KH1
Lambeth, D1
Quinn, MT1
Touyz, RM1

Other Studies

1 other study available for calmidazolium and Innate Inflammatory Response

ArticleYear
Nicotinamide adenine dinucleotide phosphate reduced oxidase 5 (Nox5) regulation by angiotensin II and endothelin-1 is mediated via calcium/calmodulin-dependent, rac-1-independent pathways in human endothelial cells.
    Circulation research, 2010, Apr-30, Volume: 106, Issue:8

    Topics: Angiotensin II; Calcium; Calcium Channel Blockers; Calmodulin; Cells, Cultured; Diltiazem; Endotheli

2010